A timely reminder that the study data is double-blinded.
- Forums
- ASX - By Stock
- NEU
- Ann: Trofinetide Rett syndrome clinical trial in girls aged 2-5
Ann: Trofinetide Rett syndrome clinical trial in girls aged 2-5, page-8
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.15 |
Change
-0.560(3.35%) |
Mkt cap ! $2.135B |
Open | High | Low | Value | Volume |
$16.61 | $16.65 | $16.07 | $766.9K | 46.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 439 | $16.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.18 | 445 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 16.600 |
1 | 602 | 16.590 |
3 | 3054 | 16.500 |
1 | 89 | 16.450 |
1 | 609 | 16.400 |
Price($) | Vol. | No. |
---|---|---|
16.880 | 1600 | 2 |
16.980 | 1900 | 1 |
17.000 | 5000 | 1 |
17.080 | 1500 | 1 |
17.170 | 1000 | 1 |
Last trade - 10.34am 18/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online